Mesenchymal Migration as a Therapeutic Target in Glioblastoma

Figure 3

The FAK/Src/Cas signaling network downstream from integrin receptor engagement. Downstream from this network, RhoA, Rac1, and Cdc42 induce cytoskeletal changes that regulate cell migration.